Study Describes Motor Sign Phenotypes of People with Genetic FTD
A study published in the journal Neurology sets out to describe observable attributes and patterns in motor signs (known as motor sign phenotypes) associated with genetic FTD, and to investigate their association with…
Read MorePilot Study Looks into Benefits of Therapeutic Exercise for People with PSP
A study published in Frontiers in Neurology investigates the benefits of a tailored, therapeutic exercise program for people with progressive supranuclear palsy (PSP). PSP falls into the category of FTD…
Read MoreADDF Chief Executive and Chief Science Officers Discuss Advancing Dementia Diagnoses
Alzheimer’s Drug Discovery Foundation (ADDF) Chief Executive Officer Mark Roithmayr and co-founder and Chief Science Officer Howard Fillit, MD, discussed advances in diagnostic methods for Alzheimer’s disease (AD) and FTD…
Read More“Forget Me Not Village” Aims to Bring Dementia Village Model to Rural U.S.
A recent article in The News Review spotlighted the founder of “Forget Me Not Village,” a care facility that uses a “dementia village” model to give residents significant freedom in…
Read MoreAFTD Advisor M.-Marsel Mesulam Appears in Podcast to Discuss Recent PPA Study
Medical Advisory Council member M.-Marsel Mesulam, MD, recently appeared in an episode of The Brain Podcast to discuss a recent study on primary progressive aphasia (PPA) and offer insights on…
Read MoreTips and Advice: Using Medication to Alleviate FTD Symptoms
While there are currently no FDA-approved therapeutics to treat FTD directly, some people benefit from asking their healthcare providers about medications to help with some of the symptoms of FTD…
Read More